Chih-Ming Ho

ORCID: 0000-0003-0634-0439 · 5 papers in corpus
observational 2022
Cancers ·doi:10.3390/cancers14071746

This large-scale study aimed to determine the long-term influences of potential prognostic predictors and progression-free interval (PFI) criteria for grading platinum-sensitivity in ovarian clear cell carcinoma (OCCC). We retrospectively r…

lab-animal 2015
BMC cancer ·doi:10.1186/s12885-015-1744-5

BACKGROUND: Methylation of HIN-1 is associated with poor outcomes in patients with ovarian clear cell carcinoma (OCCC), which is regarded to be an aggressive, chemo-resistant histological subtype. This study aimed to evaluate whether 5-aza-…

lab-animal 2012
Journal of Biomedical Science ·doi:10.1186/1423-0127-19-23

BACKGROUND: At least one-third of epithelial ovarian cancers are associated with the development of ascites containing heterogeneous cell populations, including tumor cells, inflammatory cells, and stromal elements. The components of ascite…

other 2012
Molecular cancer ·doi:10.1186/1476-4598-11-53

BACKGROUND: This study is to analyze promoter methylation of various tumor suppressor genes in different types of ovarian carcinoma and to identify potential therapeutic targets of ovarian clear cell adenocarcinoma (OCCA). MATERIALS AND ME…

nonrandomized-trial 2003
Gynecologic Oncology ·doi:10.1016/s0090-8258(02)00156-7

OBJECTIVE: The aim was to determine the benefits of lymphadenectomy and paclitaxel plus carboplatin chemotherapy for stage I ovarian clear cell carcinoma (defined as intra-abdominal disease confined to the ovaries). METHODS: Twenty patient…